Article Versions Notes

Roumen L, Sanders MPA, Vroling B, De Esch IJP, De Vlieg J, Leurs R, Klomp JPG, Nabuurs SB, De Graaf C. In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions. Pharmaceuticals. 2011; 4(9):1196-1215. https://doi.org/10.3390/ph4091196

Roumen, Luc, Marijn P.A. Sanders, Bas Vroling, Iwan J.P. De Esch, Jacob De Vlieg, Rob Leurs, Jan P.G. Klomp, Sander B. Nabuurs, and Chris De Graaf. 2011. "In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions" Pharmaceuticals 4, no. 9: 1196-1215. https://doi.org/10.3390/ph4091196

Roumen, L., Sanders, M. P. A., Vroling, B., De Esch, I. J. P., De Vlieg, J., Leurs, R., Klomp, J. P. G., Nabuurs, S. B., & De Graaf, C. (2011). In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions. Pharmaceuticals, 4(9), 1196-1215. https://doi.org/10.3390/ph4091196